MBB Public Markets I LLC Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

MBB Public Markets I LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1,848.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,066 shares of the company’s stock after purchasing an additional 13,344 shares during the period. MBB Public Markets I LLC’s holdings in HCA Healthcare were worth $4,519,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. CreativeOne Wealth LLC purchased a new position in HCA Healthcare in the 1st quarter worth approximately $231,000. New Mexico Educational Retirement Board grew its holdings in HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares in the last quarter. KBC Group NV lifted its holdings in HCA Healthcare by 60.6% in the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after buying an additional 138,146 shares in the last quarter. Kingswood Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the first quarter worth about $566,000. Finally, Teachers Retirement System of The State of Kentucky grew its stake in HCA Healthcare by 15.6% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock valued at $53,922,000 after purchasing an additional 26,919 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1 %

Shares of HCA stock opened at $403.35 on Friday. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $409.42. The stock has a fifty day moving average of $378.91 and a two-hundred day moving average of $343.05. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The firm has a market capitalization of $105.64 billion, a PE ratio of 20.11, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the company earned $4.29 EPS. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. As a group, research analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insiders Place Their Bets

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

HCA has been the subject of several research analyst reports. Leerink Partners increased their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Monday, August 19th. Finally, StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.